HRT Financial’s Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( CHAQ.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-17,660
Closed -$11K – 4019
2021
Q2
$11K Hold
17,660
– – ﹤0.01% 2747
2021
Q1
$16K Hold
17,660
– – ﹤0.01% 2607
2020
Q4
$17K Hold
17,660
– – ﹤0.01% 1746
2020
Q3
$12K Buy
+17,660
New +$12.3K ﹤0.01% 1804

HRT Financial's CHAQ.WS Position: Q3 2021 in Review

HRT Financial sold out of Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( (CHAQ.WS) in Q3 2021, closing a stake of 17,660 shares — an estimated $11K sold.

HRT Financial first reported a position in CHAQ.WS in Q3 2020 and held it in 4 quarters. The position peaked at $17K in Q4 2020. 0 funds tracked by Wall St. Rank hold CHAQ.WS as of Q3 2021.

  • HRT Financial reported no remaining Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position as of Q3 2021 after selling out during the quarter.
  • HRT Financial sold 17,660 Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( shares in Q3 2021, an estimated $11K.
  • HRT Financial first reported a position in Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( in Q3 2020 and held it in 4 quarters.
  • HRT Financial's Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position peaked at $17K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( as of Q3 2021.

Based on HRT Financial's 13F filing for Q3 2021, filed 15 Nov 2021.